Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 May 5:13:52.
doi: 10.3389/fnmol.2020.00052. eCollection 2020.

The Delta-Opioid Receptor; a Target for the Treatment of Pain

Béatrice Quirion  1 , Francis Bergeron  1 , Véronique Blais  1 , Louis Gendron  1
Affiliations
Review

The Delta-Opioid Receptor; a Target for the Treatment of Pain

Béatrice Quirion et al. Front Mol Neurosci. .

Abstract

Nowadays, pain represents one of the most important societal burdens. Current treatments are, however, too often ineffective and/or accompanied by debilitating unwanted effects for patients dealing with chronic pain. Indeed, the prototypical opioid morphine, as many other strong analgesics, shows harmful unwanted effects including respiratory depression and constipation, and also produces tolerance, physical dependence, and addiction. The urgency to develop novel treatments against pain while minimizing adverse effects is therefore crucial. Over the years, the delta-opioid receptor (DOP) has emerged as a promising target for the development of new pain therapies. Indeed, targeting DOP to treat chronic pain represents a timely alternative to existing drugs, given the weak unwanted effects spectrum of DOP agonists. Here, we review the current knowledge supporting a role for DOP and its agonists for the treatment of pain. More specifically, we will focus on the cellular and subcellular localization of DOP in the nervous system. We will also discuss in further detail the molecular and cellular mechanisms involved in controlling the cellular trafficking of DOP, known to differ significantly from most G protein-coupled receptors. This review article will allow a better understanding of how DOP represents a promising target to develop new treatments for pain management as well as where we stand as of our ability to control its cellular trafficking and cell surface expression.

Keywords: G protein-coupled receptors; delta-opioid receptor; pain; primary afferents; trafficking.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Abraira V. E., Ginty D. D. (2013). The sensory neurons of touch. Neuron 79, 618–639. 10.1016/j.neuron.2013.07.051 - DOI - PMC - PubMed
    1. Aho S., Li K., Ryoo Y., McGee C., Ishida-Yamamoto A., Uitto J., et al. . (2004). Periplakin gene targeting reveals a constituent of the cornified cell envelope dispensable for normal mouse development. Mol. Cell. Biol. 24, 6410–6418. 10.1128/mcb.24.14.6410-6418.2004 - DOI - PMC - PubMed
    1. Almeida T. F., Roizenblatt S., Tufik S. (2004). Afferent pain pathways: a neuroanatomical review. Brain Res. 1000, 40–56. 10.1016/j.brainres.2003.10.073 - DOI - PubMed
    1. Apkarian A. V., Bushnell M. C., Treede R. D., Zubieta J. K. (2005). Human brain mechanisms of pain perception and regulation in health and disease. Eur. J. Pain 9, 463–484. 10.1016/j.ejpain.2004.11.001 - DOI - PubMed
    1. Arvidsson U., Dado R. J., Riedl M., Lee J. H., Law P. Y., Loh H. H., et al. . (1995). delta-Opioid receptor immunoreactivity: distribution in brainstem and spinal cord, and relationship to biogenic amines and enkephalin. J. Neurosci. 15, 1215–1235. 10.1523/jneurosci.15-02-01215.1995 - DOI - PMC - PubMed

LinkOut - more resources